Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
CANCADO, Rodolfo Delfini
NAOUM, Flavio Augusto
BRISSOT, Pierre
Citação
BMC MEDICAL GENETICS, v.19, article ID 3, 5p, 2018
Resumo
Background: Hereditary hemochromatosis (HH) encompasses a group of autosomal recessive disorders mainly characterized by enhanced intestinal absorption of iron and its accumulation in parenchymal organs. HH diagnosis is based on iron biochemical and magnetic resonance imaging (MRI) assessment, and genetic testing. Questionnaires, such as SF-36 (short form health survey), have been increasingly used to assess the impact of diseases on the patient's quality of life (QL). In addition, different genotypes are identified as results of genetic tests in patients with suspected primary iron overload. In the present study, our aim was to evaluate whether domains of QL are different according to genotypic groups in patients suspected of HH. Methods: Seventy-nine patients with primary iron overload were included and two genotypic groups were formed (group 1: homozygous genotype for the HFE p.Cys282Tyr mutation; group 2: other genotypes). Results: Group 1 had higher means of plasma transferrin saturation (86 +/- 19%) and serum ferritin (1669 +/- 1209 ng/mL) compared to group 2 (71 +/- 12%, 1252 +/- 750 ng/mL, respectively; p = 0.001). Four domains were significantly different among groups 1 and 2: physical functioning (p = 0.03), bodily pain (p = 0.03), vitality (p = 0.02) and social functioning (p = 0.01). Conclusions: Our main finding was that patients with p. Cys282Tyr homozygosity had a worse QL scenario assessed by SF-36, compared with patients with iron overload without the same genotype. Being aware of this relationship between genotypes and QL might be helpful in the overall management of patients suspected of hereditary hemochromatosis.
Palavras-chave
Hereditary hemochromatosis, Quality of life, Short form health survey, SF-36
Referências
- Brissot P, 2016, EXPERT REV GASTROENT, V10, P359, DOI 10.1586/17474124.2016.1119043
- Campolina AG, 2008, ACTA REUMATOL PORT, V33, P127
- Campolina AG, 2011, CIENC SAUDE COLETIVA, V16, P2919, DOI 10.1590/S1413-81232011000600029
- Campos MO, 2008, REV BAIANA SAUDE PUB, V32, P232
- Cancado R, 2015, EUR J HAEMATOL, V95, P545, DOI 10.1111/ejh.12530
- Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143
- de Graaff B, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0431-9
- GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009
- Santos PCJD, 2010, GENET TEST MOL BIOMA, V14, P803, DOI 10.1089/gtmb.2010.0056
- Santos PCL, 2011, CLIN CHEM LAB MED, V49, P1633, DOI 10.1515/CCLM.2011.654
- KUYKEN W, 1995, SOC SCI MED, V41, P1403
- Laguardia Josué, 2013, Rev. bras. epidemiol., V16, P889, DOI 10.1590/S1415-790X2013000400009
- Meiser Bettina, 2005, J Genet Couns, V14, P453, DOI 10.1007/s10897-005-6192-y
- Porto G, 2016, EUR J HUM GENET, V24, P479, DOI 10.1038/ejhg.2015.128
- ROGERSON RJ, 1995, SOC SCI MED, V41, P1373, DOI 10.1016/0277-9536(95)00122-N
- Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497
- Santos PCJL, 2010, BLOOD CELL MOL DIS, V45, P302, DOI 10.1016/j.bcmd.2010.08.008
- Santos Paulo Caleb Júnior de Lima, 2012, Rev. Bras. Hematol. Hemoter., V34, P311, DOI 10.5581/1516-8484.20120079
- Santos PC, BLOOD CELLS MOL DIS, V46, P302
- Seidl E., 2004, CAD SAUDE PUBLICA, V20, P580, DOI 10.1590/S0102-311X2004000200027
- Shaheen NJ, 2003, AM J GASTROENTEROL, V98, P1175, DOI 10.1016/S0002-9270(03)00109-6
- Fonseca PFS, 2016, ACTA HAEMATOL-BASEL, V135, P228, DOI 10.1159/000444119
- van der Plas SM, 2007, QUAL LIFE RES, V16, P375, DOI 10.1007/s11136-006-9131-y
- Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
- Ware JE, 1993, SF 36 HLTH SURVEY MA